ALKAL2 Gene

Name ALK and LTK ligand 2
Description Enables protein tyrosine kinase activator activity and signaling receptor binding activity. Involved in cell surface receptor protein tyrosine kinase signaling pathway; positive regulation of MAPK cascade; and positive regulation of neuron projection development. Is active in extracellular space. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n ALKAL2, also known as FAM150B or augmentor‑α (AUG‑α), is a potent physiological ligand for the anaplastic lymphoma kinase (ALK) receptor tyrosine kinase. Binding of ALKAL2 to ALK (and the related LTK receptor) occurs with high affinity, resulting in robust receptor activation and downstream signaling through pathways such as MAP kinase. This ligand–receptor engagement has been demonstrated to drive “superactivation” of ALK, including in settings where oncogenic ALK mutants are present, thereby contributing to tumorigenic processes observed in cancers such as neuroblastoma (see"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "and."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, ALKAL2 is localized to chromosome 2p, a region that is often co‐amplified with ALK and MYCN in neuroblastoma, indicating that increased ALKAL2 expression may contribute to tumor progression even in the absence of ALK mutations."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " In addition to its role in oncogenic signaling, genetic studies in murine models have revealed that deletion of augmentor‑α (ALKAL2) results in a lean phenotype with increased physical activity and resistance to diet‑induced obesity, suggesting that ALKAL2 is also a critical regulator of energy homeostasis and metabolic control."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Complementary biochemical analyses have shown that both full‑length ALKAL2 and its truncated variants maintain the capacity to stimulate ALK and LTK phosphorylation and downstream signaling responses. These findings highlight the versatility of ALKAL2 in modulating receptor activity and underscore its potential as a therapeutic target in ALK‑driven diseases"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "and."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jikui Guan, Ganesh Umapathy, Yasuo Yamazaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.09811"}], "href": "https://doi.org/10.7554/eLife.09811"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26418745"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26418745"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Andrey V Reshetnyak, Phillip B Murray, Xiarong Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1520099112"}], "href": "https://doi.org/10.1073/pnas.1520099112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26630010"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26630010"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Niloufar Javanmardi, Susanne Fransson, Anna Djos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUGα) in neuroblastoma patient samples with chromosome arm 2p rearrangements."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Chromosomes Cancer (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/gcc.22790"}], "href": "https://doi.org/10.1002/gcc.22790"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31340081"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31340081"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Mansoor Ahmed, Navjot Kaur, Qianni Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A hypothalamic pathway for Augmentor α-controlled body weight regulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.2200476119"}], "href": "https://doi.org/10.1073/pnas.2200476119"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35412887"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35412887"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Andrey V Reshetnyak, Jyotidarsini Mohanty, Francisco Tomé, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a biologically active fragment of ALK and LTK-Ligand 2 (augmentor-α)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1807881115"}], "href": "https://doi.org/10.1073/pnas.1807881115"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30061385"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30061385"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Elizabeth S Mo, Qianni Cheng, Andrey V Reshetnyak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alk and Ltk ligands are essential for iridophore development in zebrafish mediated by the receptor tyrosine kinase Ltk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1710254114"}], "href": "https://doi.org/10.1073/pnas.1710254114"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29078341"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29078341"}]}]}]}
NCBI Gene ID 285016
API
Download Associations
Predicted Functions View ALKAL2's ARCHS4 Predicted Functions.
Co-expressed Genes View ALKAL2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View ALKAL2's ARCHS4 Predicted Functions.

Functional Associations

ALKAL2 has 647 functional associations with biological entities spanning 6 categories (functional term, phrase or reference, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 23 datasets.

Click the + buttons to view associations for ALKAL2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of ALKAL2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
CellMarker Gene-Cell Type Associations cell types associated with ALKAL2 gene from the CellMarker Gene-Cell Type Associations dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of ALKAL2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing ALKAL2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with ALKAL2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with ALKAL2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with ALKAL2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
GO Biological Process Annotations 2025 biological processes involving ALKAL2 gene from the curated GO Biological Process Annotations2025 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by ALKAL2 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of ALKAL2 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of ALKAL2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with ALKAL2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
HuBMAP ASCT+B Annotations cell types associated with ALKAL2 gene from the HuBMAP ASCT+B dataset.
HuBMAP ASCT+B Augmented with RNA-seq Coexpression cell types associated with ALKAL2 gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset.
HuBMAP Azimuth Cell Type Annotations cell types associated with ALKAL2 gene from the HuBMAP Azimuth Cell Type Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of ALKAL2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of ALKAL2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
Reactome Pathways 2024 pathways involving ALKAL2 protein from the Reactome Pathways 2024 dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of ALKAL2 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of ALKAL2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of ALKAL2 gene from the RummaGEO Gene Perturbation Signatures dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of ALKAL2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with ALKAL2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.